CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population

P Borgiani, C Ciccacci, V Forte, E Sirianni, L Novelli… - 2009 - Future Medicine
Introduction: It is known that warfarin treatment is problematic, due to its narrow therapeutic
range and to the great interindividual variability. Numerous papers have shown the important …

[HTML][HTML] Genetic factors in systemic lupus erythematosus: contribution to disease phenotype

…, C Perricone, P Borgiani, C Ciccacci… - Journal of immunology …, 2015 - hindawi.com
Genetic factors exert an important role in determining Systemic Lupus Erythematosus (SLE)
susceptibility, interplaying with environmental factors. Several genetic studies in various SLE …

Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes

C Ciccacci, R Morganti, D Di Fusco, C D'Amato… - Acta Diabetologica, 2014 - Springer
Diabetic polyneuropathy (DPN) and cardiovascular autonomic neuropathy (CAN) are common
type 2 diabetes complications with a large inter-individual variability in terms of clinical …

TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy

C Ciccacci, D Di Fusco, L Cacciotti, R Morganti… - Acta …, 2013 - Springer
Type 2 diabetes (T2DM) is a complex disease resulting from the contribution of both
environmental and genetic factors. Recently, the list of genes implicated in the susceptibility to …

[HTML][HTML] Genetic tests and genomic biomarkers: regulation, qualification and validation

G Novelli, C Ciccacci, P Borgiani… - Clinical cases in …, 2008 - ncbi.nlm.nih.gov
The identification of new risk factors for specific diseases is an enduring theme in medical
research. Advances in molecular biology, genetics, and computational biology are …

MicroRNA genetic variations: association with type 2 diabetes

C Ciccacci, D Di Fusco, L Cacciotti, R Morganti… - Acta …, 2013 - Springer
MicroRNAs are small single-stranded molecules that have emerged as important genomic
regulators in different pathways. Different studies have shown that they are implicated in the …

Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique

C Ciccacci, P Borgiani, S Ceffa, E Sirianni… - …, 2010 - Future Medicine
Aims: Nevirapine is widely used to treat HIV-1 infection to prevent mother-to-child transmission;
unfortunately adverse drug reactions have been reported. Our aim was to identify genes/…

[HTML][HTML] A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene

C Ciccacci, C Perricone, F Ceccarelli, S Rufini… - PLoS …, 2014 - journals.plos.org
Background Systemic lupus erythematosus (SLE) is an autoimmune disease with complex
pathogenesis in which genes and environmental factors are involved. We aimed at analyzing …

Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study

C Ciccacci, D Di Fusco, MC Marazzi, I Zimba… - European journal of …, 2013 - Springer
Purpose Nevirapine (NVP) is a non-nucleoside reverse transcriptase inhibitor, widely
prescribed for type 1 human immunodeficiency virus infection. A small proportion of individuals …

TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development

C Perricone, C Ciccacci, F Ceccarelli, D Di Fusco… - Immunogenetics, 2013 - Springer
Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease. Although genetic
factors confer susceptibility to the disease, only 15 % of the genetic contribution has been …